|Mr. Omar S. Ishrak||Chairman and Chief Exec. Officer||7.71M||13.56M||61|
|Mr. Bradley E. Lerman||Sr. VP, Gen. Counsel and Corp. Sec.||1.97M||N/A||60|
|Mr. Michael J. Coyle||Exec. VP and Group Pres of Cardiac & Vascular Group||2.56M||N/A||55|
|Mr. Bryan C. Hanson||Exec. VP and Group Pres of Minimally Invasive Therapies Group||1.76M||N/A||50|
|Mr. Gary L. Ellis||Consultant||2.91M||N/A||61|
Medtronic plc manufactures and sells device-based medical therapies worldwide. The companys Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The companys Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.
Medtronic plc’s ISS Governance QualityScore as of May 1, 2017 is 4. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 7; Compensation: 1.